Evaluation of von Willebrand factor activity in factor VIII/von Willebrand factor concentrates with the automated von Willebrand factor: Activity IL test

Blood Coagulation and Fibrinolysis

Volumn 21, Issue 3, 2010, Pages 221-228

  Mori, Filippo ^a   Rossi, Paola ^a   Nardini, Ilaria ^a   Gambelli, Davide ^a   Farina, Claudio ^a  

^a Castelvecchio Pascoli   (Italy)

Author keywords

HemosIL; Ristocetin cofactor; Von Willebrand factor; Von Willebrand factor factor VIII concentrate; Von Willebrand factor:activity; Von Willebrand ristocetin cofactor

Indexed keywords

BLOOD CLOTTING FACTOR 7; COLLAGEN BINDING PROTEIN; EMOCLOT; RISTOCETIN; UNCLASSIFIED DRUG; VON WILLEBRAND FACTOR;

ACCURACY; ARTICLE; ASSAY; BLOOD CLOTTING; CORRELATION COEFFICIENT; INTERMETHOD COMPARISON; LABORATORY TEST; PRIORITY JOURNAL; RANK SUM TEST; RELIABILITY; VALIDATION STUDY; WILCOXON SIGNED RANKS TEST;

FACTOR VIII; HEMATOLOGIC TESTS; HUMANS; LINEAR MODELS; SENSITIVITY AND SPECIFICITY; VON WILLEBRAND FACTOR;

EID: 77950284850     PISSN: 09575235     EISSN: None     Source Type: Journal    
DOI: 10.1097/MBC.0b013e3283367917     Document Type: Article

References (30)

1. Mendolicchio GL, Ruggeri ZM. New perspectives on von Willebrand factor function in hemostasis and thrombosis. Semin Hematol 2005; 42:5-14.
2. Rodeghiero F, Castaman G, Dini E. Epidemiological investigation of the prevalence of von Willebrand disease. Blood 1987; 69:454-459.
3. Werner EJ, Broxson EH, Tucher EL, Giroux DS, Shults J, Abshire TC. Prevalence of von Willebrand disease in children: a multiethnic study. J Pediatr 1993; 123:893-898.
4. Budde U, Drewke E, Mainusch K, Schneppenheim R. Laboratory diagnosis of congenital von Willebrand disease. Semin Thromb Hemost 2002; 28:173-189.
5. Lusher JM. Clinical guidelines for treating von Willebrand disease patients who are not candidates for DDAVP: a survey of European physicians. Haemophilia 1998; 4 (Suppl 3):11-14.
6. European Pharmacopoeia. 6th ed. Monograph 2.7.21. Human von Willebrand factor.
7. Weiss HJ, Hoyer LW, Rickles F, Varma A, Roger J. Quantitative assay of a plasma factor in von Willebrand's disease that is necessary for platelet aggregation. J Clin Invest 1973; 52:2701-2716.
8. Favaloro EJ, Smith J, Petinos P, Hertzberg H, Koutts J. Laboratory testing for von Willebrand disease: an assessment of current diagnostic practice and efficacy by means of a multilaboratory survey. Thromb Haemost 1999; 82:1276-1282.
9. Vanhoorelbeke K, Cauwenberghs N, Vauterin S, Schlammadinger A, Mazurier C, Deckmyn H. A reliable and reproducible ELISA method to measure ristocetin cofactor activity of von Willebrand factor. Thromb Haemost 2000; 83:107-113.
10. Murdock PJ, Woodhams BJ, Matthews KB, Pasi KJ, Goodall AH. von Willebrand factor activity detected in a monoclonal antibody-based ELISA: an alternative to the ristocetin cofactor platelet agglutination assay for diagnostic use. Thromb Haemost 1997; 78:1272-1277.
11. Miller CH, Platt SJ, Daniele C, Kaczor D. Evaluation of two automated methods for measurement of ristocetin cofactor activity of von Willebrand factor. Thromb Haemost 2002; 88:56-59.
12. Favaloro EJ. Collagen binding assay for von Willebrand factor (VWF:CB): detection of von Willebrand's disease (VWD), and discrimination of VWD subtypes, depends on collagen source. Thomb Haemost 2000; 83:127-135.
13. Paczuski R. Determination of von Willebrand factor activity with collagen-binding assay and diagnosis of von Willebrand disease: effect of collagen source and coating conditions. J Lab Clin Med 2002; 140:250-254.
14. Lethagen S, Carlson M, Hillarp A. A comparative in vitro evaluation of six von Willebrand factor concentrates. Haemophilia 2004; 10:243-249.
15. Redaelli R, Corno AR, Borroni L, Mostarda G, Nichelatti M, Morra E, Baudo F. von Willebrand factor ristocetin cofactor (VWF:RCo) assay: implementation on an automated coagulometer (ACL). J Thromb Haemost 2005; 3:2684-2688.
16. Lattuada A, Preda L, Sacchi E, Gallo L, Federici AB, Rossi E. A rapid assay for ristocetin cofactor activity using an automated coagulometer (ACL 9000). Blood Coagul Fibrinolysis 2004; 15:505-511.
17. Strandberg K, Lethagen S, Andersson K, Carlson M, Hillarp A. Evaluation of a rapid automated assay for analysis of von Willebrand ristocetin cofactor activity. Clin Appl Thromb Hemost 2006; 12:61-67.
18. Favaloro EJ, Koutts J. Laboratory assays for von Willebrand factor: relative contribution to the diagnosis of von Willebrand's disease. Pathology 1997; 29:385-391.
19. Vanhoorelbeke K, Cauwenberghs N, Vandecasteele G, Vauterin S, Deckmyn H. A reliable von Willebrand factor: ristocetin cofactor enzyme-linked immunosorbent assay to differentiate between type 1 and type 2 von Willebrand disease. Semin Thromb Haemost 2002; 28:161-166.
20. Laffan M, Brown SA, Collins PW, Cummings AM, Hill FGH, Keeling D, et al. The diagnosis of von Willebrand disease: a guideline from the UK. Haemophilia Centre Doctor's Organization. Haemophilia 2004; 10:199-217.
21. Favaloro EJ, Henniker A, Facey D, Hertzberg M. Discrimination of von Willebrand disease (VWD) subtypes: direct comparison of von Willebrand factor: collagen binding assay (VWF:CB) with monoclonal antibody (MAB) based VWF-capture systems. Thromb Haemost 2000; 84:541-547.
22. Favaloro EJ. Detection of von Willebrand disorder and identification of qualitative von Willebrand factor defects: direct comparison of commercial ELISA-based von Willebrand factor activity options. Am J Clin Pathol 2000; 114:608-618.
23. Preston FE. Laboratory diagnosis of hereditary bleeding disorders: external quality assessment. Haemophilia 1998; 4 (Suppl 2):12-18.
24. Favaloro EJ, Mehrabani PA, Koutts J. Laboratory assessment of von Willebrand factor: altered interpretation of laboratory data, and altered diagnosis of von Willebrand's disease, as influenced by the use of different VWF assays and assay conditions. Clin Appl Thromb Haemost 1997; 3:110-118.
25. Favaloro EJ, Thom J, Baker R. Assessment of current diagnostic practice and efficacy in testing for von Willebrand's disorder: results from the second Australasian multilaboratory survey. Blood Coagul Fibrinolysis 2000; 11:729-737.
26. Federici AB, Canciani MT, Forza I, Mannucci PM, Marchese P, Ware J, Ruggeri ZM. A sensitive ristocetin cofactor activity assay with recombinant glycoprotein Iba for the diagnosis of patient with low von Willebrand factor levels. Haematologica 2004; 89:77-85.
27. Pinol M, Sales M, Costa M, Tosetto A, Canciani MT, Federici AB. Evaluation of a new turbidimetric assay for von Willebrand factor activity useful in the general screening of von Willebrand disease. Haematologica 2007; 92:712-713.
28. De Vleeschauwer A, Devreese K. Comparison of a new automated von Willebrand factor activity assay with an aggregation von Willebrand ristocetin cofactor activity assay for the diagnosis of von Willebrand disease. Blood Coagul Fibrinolysis 2006; 17:353-358.
29. Salem RO, Van Cott EM. A new automated screening assay for the diagnosis of von Willebrand disease. Am J Clin Pathol 2007; 127:730-735.
30. Sucker C, Senft B, Scharf RE, Zotz RB. Determination of von Willebrand factor activity: evaluation of the HemosIL assay in comparison with established procedures. Clin Appl Thromb Haemost 2006; 12:305-310.